Evaluating Latest Evidence and Treatment Targets in Moderate to Severe Atopic Dermatitis : Episode 5

Opinion

Video

July 22, 2024

Ongoing Studies in Atopic Dermatitis and Recommendations for Clinicians

Author(s):

Christopher G. Bunick, MD, PhD

Christopher Bunick, MD, PhD, offers advice for clinicians treating patients with atopic dermatitis.

EP: 1.Systemic Treatments in Atopic Dermatitis: Use and Treatment Inertia

EP: 2.Atopic dermatitis Clinical Trial Endpoints

EP: 3.Treatment and Patient Reported Outcomes in Atopic Dermatitis

EP: 4.Head-to-head Study of Upadacitnib and Dupilumab in Atopic Dermatitis (Level Up)

EP: 5.Ongoing Studies in Atopic Dermatitis and Recommendations for Clinicians

Please summarize recently presented/published results with other systemic agents in atopic dermatitis.
What advice do you have for clinicians taking care of patients with atopic dermatitis?

Related Videos

Ahmad Masri, MD, MS | Credit: Oregon Health and Science University

Ahmad Masri, MD, MS | Credit: Oregon Health and Science University

Stephen Nicholls, MBBS, PhD | Credit: Monash University

Marianna Fontana, MD, PhD: Nex-Z Shows Promise in ATTR-CM Phase 1 Trial | Image Credit: Radcliffe Cardiology

Zerlasiran Achieves Durable Lp(a) Reductions at 60 Weeks, with Stephen J. Nicholls, MD, PhD | Image Credit: Monash University

Gaith Noaiseh, MD: Nipocalimab Improves Disease Measures, Reduces Autoantibodies in Sjogren’s

4 experts are featured in this series.

4 experts are featured in this series.

A. Sidney Barritt, MD | Credit: UNC School of Medicine

Do Not Sell My Information

Terms & Conditions

Contact Info

2 Commerce Drive
Cranbury, NJ 08512

© 2024 MJH Life Sciences

All rights reserved.